(02) 9850 4000
GlyTherix
  • Home
  • Company
    • Financial Statements
  • Product Pipeline
  • For Investors
  • News
  • Contact Us
Select Page

Industry News: MTPConnect’s COVID-19 Impact Report

by GlyTherix | Jun 17, 2020

MTP Industry News
  • Facebook
  • Twitter
  • Google+
  • LinkedIn

Explore the impact of the pandemic lockdown on medtech, biotech and pharma sectors in Australia by downloading MTPConnect’s  COVID-19 Impact Report.

MORE INFO

Would you like to talk with Glytherix about:

  • Investing in us?
  • Partnering with us?
  • Media events?
  • Some feedback?

ENQUIRIES

Address
Suite 2, Ground Floor, 
75 Talavera Road, 
Macquarie Park, NSW 2113, 
Australia

Phone
Intl: +612 9850 4000
Aust: 02 9850 4000
(Compare your time zone with Sydney here)

Recent Posts

  • GlyTherix awarded NSW Government TechVoucher to evaluate efficacy of our cancer antibody Miltuximab®
  • GlyTherix is a recipient of the first round of the TIA pipeline accelerator 2020-21 scheme
  • Carina Biotech and GlyTherix enter into CAR-T partnership

RECENT POSTS

  • GlyTherix awarded NSW Government TechVoucher to evaluate efficacy of our cancer antibody Miltuximab®
  • GlyTherix is a recipient of the first round of the TIA pipeline accelerator 2020-21 scheme
  • Carina Biotech and GlyTherix enter into CAR-T partnership
  • GlyTherix Awarded $3 Million Co-operative Research Centre Project Grant

ENQUIRIES

Address
Suite 2, Ground Floor, 
75 Talavera Road, 
Macquarie Park, NSW 2113, 
Australia

Phone
Intl: +612 9850 4000
Aust: 02 9850 4000
(Compare your time zone with Sydney here)

MORE INFO

Would you like to talk with Glytherix about:

  • Investing in us?
  • Partnering with us?
  • Media events?
  • Some feedback?
  • Home
  • News
  • Terms of Use
  • Privacy Policy
  • Contact Us

COPYRIGHT 2021 | GLYTHERIX - ALL RIGHTS RESERVED